Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure Appointed director
|
MedMen Enterprises, Inc. (MMNFF)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/11/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/23/2023 |
8-K
| Changes in Registrant's Certifying Accountant, Regulation FD Disclosure, Financial Statements and Exhibits I... |
08/26/2022 |
8-K
| Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits &n...
Docs:
|
"FIRST Amendment TO ASSET PURCHASE AGREEMENT This FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT is entered into this 31st day of July 2022, by and among MME Florida, LLC, a Florida limited liability company , MM Enterprises USA, LLC, a Delaware limited liability company , and Green Sentry Holdings, LLC, a Florida limited liability company . Each of Seller, MME USA, and Buyer are referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not otherwise defined or redefined herein shall have the meanings set forth in the Original Agreement . RECITALS WHEREAS, the Parties previously entered into that certain Asset Purchase Agreement, dated as of February 27, 2022 ; WHEREAS, the Parties desire to extend the outside closing date of the transaction, WH...",
"RECITALS WHEREAS, the Parties previously entered into that certain Asset Purchase Agreement, dated as of February 27, 2022 , as amended by that certain First Amendment to Asset Purchase Agreement dated July 31, 2022 ; WHEREAS, the Parties desire to extend the outside closing date of the transaction, WHEREAS, pursuant to Section 9.08 of the Asset Purchase Agreement, the Asset Purchase Agreement may be amended upon the written agreement of all Parties to the Asset Purchase Agreement; and WHEREAS, the Parties desire to further amend the Asset Purchase Agreement and the Disclosure Schedules as set forth herein. NOW, THEREFORE, in consideration of the valuable consideration set forth herein, the sufficiency of which is hereby acknowledged, the Parties agree as follows: 1. The defined term “Defe...",
"MedMen Completes Sale of Florida Assets 08/22/2022" |
|
05/25/2022 |
8-K
| Quarterly results |
05/03/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/26/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibit... |
03/04/2022 |
8-K
| Quarterly results |
02/22/2022 |
8-K
| Quarterly results |
02/14/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/03/2022 |
8-K
| Quarterly results |
11/26/2021 |
8-K
| Appointed a new director |
11/12/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
|
"MedMen Announces Board Changes LOS ANGELES, November 8, 2021 -- MedMen Enterprises Inc. , a premier cannabis retailer with operations across the United States, today announced that David Hsu and Ed Record have been elected to the Company’ s Board of Directors, effective immediately. Hsu is an expert in financial and operational turnarounds. Most recently he served as Chief Operating Officer of cannabis company Cronos Group, where he was responsible for international expansion, construction, cultivation and manufacturing. Prior to joining Cronos Group, Hsu spent more than a decade consulting with Deloitte and CRG Partners, a premier turnaround consulting firm, where he operated and managed distressed companies with revenues of more than $500 million. Record has deep retail experience, over..." |
|
10/29/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/19/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/24/2021 |
8-K
| Quarterly results |
09/23/2021 |
8-K
| Quarterly results |
08/20/2021 |
8-K
| Quarterly results |
07/15/2021 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
05/17/2021 |
8-K
| Quarterly results |
05/11/2021 |
8-K
| Quarterly results |
03/24/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat... |
03/02/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
02/22/2021 |
8-K
| Quarterly results |
02/16/2021 |
8-K
| Quarterly results |
01/15/2021 |
8-K
| Quarterly results |
01/07/2021 |
8-K
| Quarterly results |
12/28/2020 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
12/18/2020 |
8-K
| Appointed a new director
Docs:
|
"ABOUT MEDMEN MedMen is a cannabis retailer with flagship locations in California, Nevada, Illinois, Florida, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen and The MedMen Foundation at www.medmen.com. SOURCE: MedMen Enterprises MEDIA CONTACTS: Julian Labagh Email: [email protected] INVESTOR RELATIONS CONTACT: Zeeshan Hyder Email: [email protected]",
"MedMen Announces Tom Lynch Elected",
"MedMen Appoints Reece Fulgham as Interim Chief Financial Officer" |
|
12/07/2020 |
8-K
| Quarterly results |
|
|